Cardiovascular Devices: Cardiac Rhythm Management (CRM) Devices

• Publication date: January 2011

Industry expert's new report, “” provides key data, information and analysis on the global cardiac rhythm management devices industry . The report provides industry landscape, competitive landscape and industry trends information the cardiac rhythm management devices industry . The report provides comprehensive data on the major industry developments affecting the industry, and key analytical content on the industry dynamics. The rep...

Industry expert's new report, “” provides key data, information and analysis on the global cardiac rhythm management devices industry . The report provides industry landscape, competitive landscape and industry trends information the cardiac rhythm management devices industry . The report provides comprehensive data on the major industry developments affecting the industry, and key analytical content on the industry dynamics. The report also reviews the competitive landscape and technology offerings.

Scope of the Research

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key sectors covered include Cardiac Resynchronisation Therapy (Cardiac Resynchronisation Therapy – Defibrillators, Cardiac Resynchronisation Therapy – Pacemakers), Implantable Cardioverter Defibrillators (Dual Chamber Implantable Cardioverter Defibrillators, Single Chamber Implantable Cardioverter Defibrillators), and Pacemakers (Dual Chamber Pacemakers, Single Chamber Pacemakers).
- Annualized industry revenues data from 2002 to 2009, projection forward for 7 years to 2016. Firms shares data for 2009.
- Qualitative analysis of key industry trends, industry drivers, and restraints by each category within cardiac rhythm management devices industry .
- The report also covers data on the leading industry players, the competitive landscape, and the leading new product development and technologies.
- Key Companies covered include Medtronic, St. Jude Medical, and Boston Scientific Corporation.

Why Should You Get This Report?

- Develop business strategies by understanding the trends and developments that are driving the cardiac rhythm management devices industry globally.
- Design and develop your product development, industry ing and sales strategies.
- Develop successful market-entry strategies .
- Identify key players best positioned to take advantage of the emerging industry opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the cardiac rhythm management devices industry landscape? – Identify, understand and decide.
- Make more informed business decisions from the insightful and in-depth analysis of the global cardiac rhythm management devices industry and the factors shaping it.

Global Cardiovascular Devices Industry

1 Table of Contents 3
I. 1 List of Data tables 6
I. 2 List of Charts 7

II Introduction 8
II. 1 GlobalData Report Guidance 8
3 Disease Data 9
III. 1 Pathophysiology: Cardiac Arrhythmias 9
III. 1.1 Tachycardia (Too Fast) 9
III. 1.2 Bradycardia (Too Slow) 10
III. 1.3 Fibrillation (Quivering) 10
III. 1.4 Other Cardiac Disorders 11
III. 2 Pathophysiology: Congestive Heart Failure (CHF) 11
III. 3 Device Overview 12
III. 3.1 Pacemaker 12
III. 3.2 Implantable Cardioverter Defibrillator (ICD) 13
III. 3.3 Cardiac Resynchronization Therapy (CRT) 13

IV Cardiac Rhythm Management, Global, March ket Characterization 15
IV. 1 Cardiac Rhythm Management March ket, Global, Sales (USD Million), Historical data, 2002–2009 15
IV. 2 Cardiac Rhythm Management March ket, Global, Sales (USD Million), Forecasted data, 2009–2016 16
IV. 3 Cardiac Rhythm Management March ket, Key Technology Trends 17
IV. 3.1 MRI friendly Pacemakers 17
IV. 3.2 Wireless Pacemakers 17
IV. 3.3 Percutaneous Implantable ICDs 17
IV. 3.4 Automatic Mode Switching by Managed Ventricular Pacing (MVP pacing) 17
IV. 3.5 Automatic Diagnosis 17
IV. 3.6 Minute Ventilation Blended Sensor 18
IV. 3.7 Subcutaneous ICDs 18
IV. 4 Cardiac Rhythm Management March ket, Global, March ket Dynamics 18
IV. 4.1 March ket Drivers 19
IV. 4.2 March ket Restraints 23

V Cardiac Rhythm Management March ket, Global, Segment Analysis 26
V. 1 Cardiac Resynchronisation Therapy March ket, Global, Sales (USD Million), Historical data, 2002–2009 26
V. 2 Cardiac Resynchronisation Therapy March ket, Global, Sales (USD Million), Forecasted data, 2009–2016 27
V. 3 Cardiac Resynchronisation Therapy, March ket Dynamics 28
V. 3.1 March ket Driver: The Approval of Cardiac Resynchronisation Therapy (CRT) Devices in an Expanded Number of Indications is Driving the Sales Generation in This Segment. 28
V. 3.2 March ket Restraint: Effectiveness of Clinical Outcomes through Cardiac Resynchronisation Therapy (CRT) Devices Requires Adequate Skills in Placement of Leads and Continuous Follow up to Avoid Complications 28
V. 4 Pacemakers March ket, Global, Sales (USD Million), Historical data, 2002–2009 29
V. 5 Pacemakers March ket, Global, Sales (USD Million), Forecasted data, 2009–2016 30
V. 6 Pacemakers, March ket Dynamics 31
V. 6.1 March ket Drivers 31
V. 6.2 March ket Restraint: The Demand for Pacemakers December lined Due to Better and More Reliable Technologies 31
V. 7 Implantable Cardioverter Defibrillator March ket, Global, Sales (USD Million), Historical data, 2002–2009 32
V. 8 Implantable Cardioverter Defibrillator March ket, Global, Sales (USD Million), Forecasted data, 2009–2016 33
V. 9 Implantable Cardioverter Defibrillator, March ket Dynamics 34
V. 9.1 March ket Driver: Expansion of Implantable Cardioverter Defibrillator (ICD) Use to More Number of Indications ill Increase the Patient Pool 34
V. 9.2 March ket Restraint: Studies Inferring Complications Associated with the Use of ICDs are a Huge Obstacle for March ket Growth 34

VI Cardiac Rhythm Management March ket, By Country, 2002–2016 35
VI. 1 Cardiac Rhythm Management March ket, US, Sales (USD Million), Historical data, 2002–2009 35
VI. 2 Cardiac Rhythm Management March ket, US, Sales (USD Million), Forecasted data, 2009–2016 36
VI. 3 Cardiac Rhythm Management March ket, Canada, Sales (USD Million), Historical data, 2002–2009 37
VI. 4 Cardiac Rhythm Management March ket, Canada, Sales (USD Million), Forecasted data, 2009–2016 38
VI. 5 Cardiac Rhythm Management March ket, UK, Sales (USD Million), Historical data, 2002– 2009 39
VI. 6 Cardiac Rhythm Management March ket, UK, Sales (USD Million), Forecasted data, 2009– 2016 40
VI. 7 Cardiac Rhythm Management March ket, Germany, Sales (USD Million), Historical data, 2002–2009 41
VI. 8 Cardiac Rhythm Management March ket, Germany, Sales (USD Million), Forecasted data, 2009–2016 42
VI. 9 Cardiac Rhythm Management March ket, France, Sales (USD Million), Historical data, 2002–2009 43
VI. 10 Cardiac Rhythm Management March ket, France, Sales (USD Million), Forecasted data, 2009–2016 44
VI. 11 Cardiac Rhythm Management March ket, Italy, Sales (USD Million), Historical data, 2002–2009 45
VI. 12 Cardiac Rhythm Management March ket, Italy, Sales (USD Million), Forecasted data, 2009–2016 46
VI. 13 Cardiac Rhythm Management March ket, Spain, Sales (USD Million), Historical data, 2002–2009 47
VI. 14 Cardiac Rhythm Management March ket, Spain, Sales (USD Million), Forecasted data, 2009–2016 48
VI. 15 Cardiac Rhythm Management March ket, Japan, Sales (USD Million), Historical data, 2002–2009 49
VI. 16 Cardiac Rhythm Management March ket, Japan, Sales (USD Million), Forecasted data, 2009–2016 50
VI. 17 Cardiac Rhythm Management March ket, China, Sales (USD Million), Historical data, 2002–2009 51
VI. 18 Cardiac Rhythm Management March ket, China, Sales (USD Million), Forecasted data, 2009–2016 52
VI. 19 Cardiac Rhythm Management March ket, India, Sales s (USD Million), Historical data, 2002–2009 53
VI. 20 Cardiac Rhythm Management March ket, India, Sales (USD Million), Forecasted data, 2009–2016 54
VI. 21 Cardiac Rhythm Management March ket, Australia, Sales (USD Million), Historical data, 2002–2009 55
VI. 22 Cardiac Rhythm Management March ket, Australia, Sales (USD Million), Forecasted data, 2009–2016 56
VI. 23 Cardiac Rhythm Management March ket, Brazil, Sales (USD Million), Historical data, 2002–2009 57
VI. 24 Cardiac Rhythm Management March ket, Brazil, Sales (USD Million), Forecasted data, 2009–2016 58
7 World Cardiac Rhythm Management March ket, Strategic Competitive Assessment 59
VII. 1 Cardiac Rhythm Management March ket, Key Participants 60
VII. 1.1 Medtronic 60
VII. 1.2 St. Jude Medical, Inc. 61
VII. 1.3 Boston Scientific Corporation 63
VII. 1.4 Biotronik SE & Co. KG 63
8 World Cardiac Rhythm Management March ket, Key March keted Products 65
VIII. 1 Pacemaker – Adapta with MVP Pacing System (Medtronic) 65
VIII. 1.1 Product Description 65
VIII. 1.2 Key Features 65
VIII. 1.3 Clinical Studies and Outcomes 65
VIII. 2 CRT Pacemaker – Anthem RF (St. Jude Medical, Inc.) 66
VIII. 2.1 Product Description 66
VIII. 2.2 Key Features 66
VIII. 3 CRT Defibrillator – Consulta (Medtronic) 67
VIII. 3.1 Product Description 67
VIII. 3.2 Features, Advantages and Benefits 67
VIII. 4 ALTRUA Pacemaker Family (Boston Scientific) 67
VIII. 4.1 Product Description 67
VIII. 4.2 Features, Advantages and Benefits 67
VIII. 5 Subcutaneous Implantable Defibrillator System (Cameron Health, Inc.) 68
VIII. 5.1 Product Description 68
VIII. 5.2 Features, Advantages and Benefits 68
9 World Cardiac Rhythm Management March ket: Strategic Pipeline Assessment 69
IX. 1 Pipeline Technology Assessment 69
IX. 2 Cardiac Resynchronisation Therapy, Pipeline Products 71
IX. 2.1 Protecta XT CRT-D (Medtronic, Inc.) 71
IX. 2.2 PARADYM 8770 SonR CRT-D (Sorin Group) 72
IX. 3 Pacemakers, Pipeline Products 72
IX. 3.1 Revo/EnRhythm MRI Pacemaker System (Medtronic, Inc.) 73
IX. 3.2 Reply MRI Pacemaker (Sorin Group) 73
IX. 3.3 External Cardiac Rhythm Normalizer (ECN) Pacemaker (Mathematical Bio-Solutions, Inc.) 74
IX. 3.4 INGENIO Pacemaker (Boston Scientific Corporation) 74
IX. 4 Implantable Cardioverter Defibrillators, Pipeline Products 75
IX. 4.1 PICD-Percutaneous Implantable Cardioverter Defibrillator (InnerPulse, Inc.) 75
IX. 4.2 Chronicle ICD (Medtronic, Inc.) 76
IX. 4.3 AnalySt Accel ICD (St. Jude Medical, Inc.) 77
IX. 5 Other Cardiac Rhythm Management Devices, Pipeline Products 79
IX. 5.1 Optimizer III System (Impulse Dynamics N.V) 79

X Global Cardiac Rhythm Management March ket, Deals Landscape 80
X. 1 Key Deals, 2008–2010 (mid-November ember) 80
X. 1.1 St. Jude Medical Enters into an Agreement with iRhythm Technologies (Partnership) on May 13, 2010 80
X. 1.2 Proteus Biomedical Secures US$ 25m in Series E Financing Round (Venture Financing) on April il 21, 2010 80
X. 1.3 Trivitron Signs an Agreement with Boston Scientific (Partnership) on November ember 4, 2008 80

XI Appendix 81
XI. 1 Definitions 82
XI. 1.1 Cardiac Rhythm Management 82
XI. 2 Acronyms 83
XI. 3 Sources 84
XI. 4 Research Methodology 84
XI. 5 Secondary Research 85
XI. 6 Primary Research 85
XI. 7 Models 85
XI. 8 Forecasted data s 86
XI. 9 Expert Panels 86
XI. 10 GlobalData Consulting 86
XI. 11 Contact Us 86
XI. 12 Disclaimer 86

1.1 List of Data tables

Data table 1: Cardiac Rhythm Management March ket, Global, Sales (USD Million), 2002–2009 15
Data table 2: Cardiac Rhythm Management March ket, Global, Sales (USD Million), 2009–2016 16
Data table 3: Cardiac Rhythm Management March ket, List of Device Recalls, 2004–2010 23
Data table 4: Cardiac Rhythm Management Device Recalls, Losses Due to Legal Issues 24
Data table 5: Cardiac Resynchronization Therapy March ket, Global, Sales (USD Million), 2002–2009 26
Data table 6: Cardiac Resynchronization Therapy March ket, Global, Sales (USD Million), 2009–2016 27
Data table 7: Pacemaker March ket, Global, Sales (USD Million), 2002–2009 29
Data table 8: Cardiac Resynchronization Therapy March ket, Global, Sales (USD Million), 2009–2016 30
Data table 9: Implantable Cardioverter Defibrillator March ket, Global, Sales (USD Million), 2002–2009 32
Data table 10: Implantable Cardioverter Defibrillator March ket, Global, Sales (USD Million), 2009–2016 33
Data table 11: Cardiac Rhythm Management March ket, US, Sales (USD Million), 2002–2009 35
Data table 12: Cardiac Rhythm Management March ket, US, Sales (USD Million), 2009–2016 36
Data table 13: Cardiac Rhythm Management March ket, Canada, Sales (USD Million), 2002–2009 37
Data table 14: Cardiac Rhythm Management March ket, Canada, Sales (USD Million), 2009–2016 38
Data table 15: Cardiac Rhythm Management March ket, UK, Sales (USD Million), 2002–2009 39
Data table 16: Cardiac Rhythm Management March ket, UK, Sales (USD Million), 2009–2016 40
Data table 17: Cardiac Rhythm Management March ket, Germany, Sales (USD Million), 2002–2009 41
Data table 18: Cardiac Rhythm Management March ket, Germany, Sales (USD Million), 2009–2016 42
Data table 19: Cardiac Rhythm Management March ket, France, Sales (USD Million), 2002–2009 43
Data table 20: Cardiac Rhythm Management March ket, France, Sales (USD Million), 2009–2016 44
Data table 21: Cardiac Rhythm Management March ket, Italy, Sales (USD Million), 2002–2009 45
Data table 22: Cardiac Rhythm Management March ket, Italy, Sales (USD Million), 2009–2016 46
Data table 23: Cardiac Rhythm Management March ket, Spain, Sales (USD Million), 2002–2009 47
Data table 24: Cardiac Rhythm Management March ket, Spain, Sales (USD Million), 2009–2016 48
Data table 25: Cardiac Rhythm Management March ket, Japan, Sales (USD Million), 2002–2009 49
Data table 26: Cardiac Rhythm Management March ket, Japan, Sales (USD Million), 2009–2016 50
Data table 27: Cardiac Rhythm Management March ket, China, Sales (USD Million), 2002–2009 51
Data table 28: Cardiac Rhythm Management March ket, China, Sales (USD Million), 2009–2016 52
Data table 29: Cardiac Rhythm Management March ket, India, Sales (USD Million), 2002–2009 53
Data table 30: Cardiac Rhythm Management March ket, India, Sales (USD Million), 2009–2016 54
Data table 31: Cardiac Rhythm Management March ket, Australia, Sales (USD Million), 2002–2009 55
Data table 32: Cardiac Rhythm Management March ket, Australia, Sales (USD Million), 2009–2016 56
Data table 33: Cardiac Rhythm Management March ket, Brazil, Sales (USD Million), 2002–2009 57
Data table 34: Cardiac Rhythm Management March ket, Brazil, Sales (USD Million), 2009–2016 58
Data table 35: Cardiac Rhythm Management March ket, Global, Market Shares s, Sales (USD Million), 2009 59
Data table 36: Cardiac Rhythm Management, Medtronic, March keted Products, 2010 60
Data table 37: Cardiac Rhythm Management, St. Jude Medical, Inc., March keted Products, 2010 62
Data table 38: Cardiac Rhythm Management, Boston Scientific Corporation, March keted Products, 2010 63
Data table 39: Cardiac Rhythm Management, Biotronik SE & Co. KG, March keted Products, 2010 64
Data table 40: Cardiac Resynchronisation Therapy, List of Pipeline Products, 2010 71
Data table 41: Protecta XT CRT-D, Product Status, 2010 71
Data table 42: Paradym SonR CRT-D, Product Status, 2010 72
Data table 43: Pacemakers, List of Pipeline Products, 2010 72
Data table 44: Revo MRI Pacemaker System, Product Status, 2010 73
Data table 45: Reply MRI Pacemaker, Product Status, 2010 73
Data table 46: ECN Pacemaker, Product Status, 2010 74
Data table 47: INGENIO Pacemaker, Product Status, 2010 74
Data table 48: Implantable Cardioverter Defibrillators, List of Pipeline Products, 2010 75
Data table 49: PICD, Product Status, 2010 75
Data table 50: Chronicle ICD (Medtronic, Inc), Product Status, 2010 76
Data table 51: REDUCE hf Clinical Trial Details – Chronicle ICD (Medtronic, Inc.) 76
Data table 52: AnalyST Accel ICD, Product Status, 2010 77
Data table 53: Clinical Evaluation of ST Segment Deviation Detection by SJM AnalyST and Analyst Accel Implantable Cardiac Defibrillators – AnalyST Accel ICD (ST. Jude Medical, Inc.) 78
Data table 54: Other Cardiac Rhythm Management Devices, List of Pipeline Products, 2010 79
Data table 55: Optimizer III System, Product Status, 2010 79

1.2 List of Charts

Chart 1: Cardiac Rhythm Management March ket, Global, Sales (USD Million), 2002–2009 15
Chart 2: Cardiac Rhythm Management March ket, Global, Sales (USD Million), 2009–2016 16
Chart 3: Cardiac Rhythm Management March ket, Drivers and Restraints 18
Chart 4: Cardiac Resynchronization Therapy March ket, Global, Sales (USD Million), 2002–2009 26
Chart 5: Cardiac Resynchronization Therapy March ket, Global, Sales (USD Million), 2009–2016 27
Chart 6: Pacemaker March ket, Global, Sales (USD Million), 2002–2009 29
Chart 7: Pacemaker March ket, Global, Sales (USD Million), Forecasted data, 2009–2016 30
Chart 8: Implantable Cardioverter Defibrillator March ket, Global, Sales (USD Million), 2002–2009 32
Chart 9: Implantable Cardioverter Defibrillator March ket, Global, Sales (USD Million), 2009–2016 33
Chart 10: Cardiac Rhythm Management March ket, US, Sales (USD Million), 2002–2009 35
Chart 11: Cardiac Rhythm Management March ket, US, Sales (USD Million), 2009–2016 36
Chart 12: Cardiac Rhythm Management March ket, Canada, Sales (USD Million), 2002–2009 37
Chart 13: Cardiac Rhythm Management March ket, Canada, Sales (USD Million), 2009–2016 38
Chart 14: Cardiac Rhythm Management March ket, UK, Sales (USD Million), 2002–2009 39
Chart 15: Cardiac Rhythm Management March ket, UK, Sales (USD Million), 2009–2016 40
Chart 16: Cardiac Rhythm Management March ket, Germany, Sales (USD Million), 2002–2009 41
Chart 17: Cardiac Rhythm Management March ket, Germany, Sales (USD Million), 2009–2016 42
Chart 18: Cardiac Rhythm Management March ket, France, Sales (USD Million), 2002–2009 43
Chart 19: Cardiac Rhythm Management March ket, France, Sales (USD Million), 2009–2016 44
Chart 20: Cardiac Rhythm Management March ket, Italy, Sales (USD Million), 2002–2009 45
Chart 21: Cardiac Rhythm Management March ket, Italy, Sales (USD Million), 2009–2016 46
Chart 22: Cardiac Rhythm Management March ket, Spain, Sales (USD Million), 2002–2009 47
Chart 23: Cardiac Rhythm Management March ket, Spain, Sales (USD Million), 2009–2016 48
Chart 24: Cardiac Rhythm Management March ket, Japan, Sales (USD Million), 2002–2009 49
Chart 25: Cardiac Rhythm Management March ket, Japan, Sales (USD Million), 2009–2016 50
Chart 26: Cardiac Rhythm Management March ket, China, Sales (USD Million), 2002–2009 51
Chart 27: Cardiac Rhythm Management March ket, China, Sales (USD Million), 2009–2016 52
Chart 28: Cardiac Rhythm Management March ket, India, Sales (USD Million), 2002–2009 53
Chart 29: Cardiac Rhythm Management March ket, India, Sales (USD Million), 2009–2016 54
Chart 30: Cardiac Rhythm Management March ket, Australia, Sales (USD Million), 2002–2009 55
Chart 31: Cardiac Rhythm Management March ket, Australia, Sales (USD Million), 2009–2016 56
Chart 32: Cardiac Rhythm Management March ket, Brazil, Sales (USD Million), 2002–2009 57
Chart 33: Cardiac Rhythm Management March ket, Brazil, Sales (USD Million), 2009–2016 58
Chart 34: Cardiac Rhythm Management March ket, Global, Market Shares s (%), 2009 59
Chart 35: Cardiac Rhythm Management Devices, Pipeline Technology Assessment, 2010 69
Chart 36: Cardiac Rhythm Management Devices, Key Pipeline Technologies, 2010 70

Companies mentioned
Medtronic
St. Jude Medical, Inc.
Boston Scientific Corporation
Biotronik SE & Co. KG